Novel inhibitors of potassium ion channels on human T lymphocytes. 1995

W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
Sanofi Winthrop Inc., Collegeville, Pennsylvania 19426, USA.

The in vitro biological characterization of a series of 4-(alkylamino)-1,4-dihydroquinolines is reported. These compounds are novel inhibitors of voltage-activated n-type potassium ion (K+) channels in human T lymphocytes. This series, identified from random screening, was found to inhibit [125I]charybdotoxin binding to n-type K+ channels with IC50 values ranging from 10(-6) to 10(-8) M. These analogs also inhibit whole cell n-type K+ currents with IC50 values from 10(-5) to 10(-7) M. The preparation of a series of new 4-(alkylamino)-1,4-dihydroquinolines is described. Structure-activity relationships are discussed. Naphthyl analog 7c, the best compound prepared, exhibited > 100-fold selectivity for inhibition of [125I]charybdotoxin binding to n-type K+ channels compared with inhibition of [3H]dofetilide binding to cardiac K+ channels. These compounds represent a potent and selective series of n-type K+ channel inhibitors that have the potential for further development as anti-inflammatory agents.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011804 Quinolines
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012604 Scorpion Venoms Venoms from animals of the order Scorpionida of the class Arachnida. They contain neuro- and hemotoxins, enzymes, and various other factors that may release acetylcholine and catecholamines from nerve endings. Of the several protein toxins that have been characterized, most are immunogenic. Scorpion Toxin,Scorpion Toxins,Scorpion Venom Peptide,Tityus serrulatus Venom,Scorpion Venom,alpha-Scorpion Toxin,beta-Scorpion Toxin,gamma-Scorpion Toxin,Peptide, Scorpion Venom,Toxin, Scorpion,Toxin, alpha-Scorpion,Toxin, beta-Scorpion,Venom Peptide, Scorpion,Venom, Scorpion,Venom, Tityus serrulatus,alpha Scorpion Toxin,beta Scorpion Toxin,gamma Scorpion Toxin
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
April 1989, The Journal of general physiology,
W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
January 1992, The Journal of physiology,
W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
January 1987, Advances in experimental medicine and biology,
W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
May 1997, The Journal of physiology,
W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
June 2005, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
September 1996, Biochemical pharmacology,
W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
October 1994, Molecular pharmacology,
W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
March 1990, The Journal of physiology,
W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
May 2005, The Journal of membrane biology,
W F Michne, and J W Guiles, and A M Treasurywala, and L A Castonguay, and C A Weigelt, and B Oconnor, and W A Volberg, and A M Grant, and C C Chadwick, and D S Krafte
November 1985, Journal of neuroimmunology,
Copied contents to your clipboard!